Huntington's like conditions in China, A review of published Chinese cases

Zhenzhen Zheng1, Jean-Marc Burgunder, Huifang Shang

  • 1Department of Neurology,West China Hospital, Sichuan University, Chengdu Wai Nan Guo Xue Xiang 37# Sichuan, P.R.China and Prof. M.D. Department of Neurology, University of Bern, Switzerland and University of Sichuan, Chengdu, China.

Plos Currents
|March 31, 2012
PubMed

Insights

This study reviews Huntington disease (HD) clinical characteristics in China, finding motor symptoms are most common. Further research is needed to confirm genetic diagnoses and understand regional variations in HD presentation.

Area of Science:

  • Neurology
  • Genetics
  • Epidemiology

Background:

  • International literature lacks comprehensive data on Huntington disease (HD) in China.
  • This study addresses this gap by analyzing existing Chinese literature on HD.

Purpose of the Study:

  • To thoroughly explore the clinical characteristics of Huntington disease (HD) in the Chinese population.
  • To identify patterns in disease presentation, inheritance, and progression within China.

Main Methods:

  • A systematic review of Chinese case reports on HD from 1980 to 2011.
  • Data extraction focused on clinical characteristics, family history, inheritance patterns, onset age, and symptoms.

Main Results:

  • 92 studies with 279 patients were analyzed; 82% from North China.
  • Paternal inheritance (65.5%) was more common. Mean onset age was 35.8 years.
  • Motor symptoms were predominant (99.6% with progression), followed by cognitive impairment (67.9%) and psychiatric symptoms (35.0%).

Conclusions:

  • Huntington disease is documented in Chinese literature, but molecular confirmation is infrequent.
  • Clinical features largely mirror international findings, with potential observational bias in North China and male prevalence.
  • Prospective studies with genetic testing are recommended to validate findings and improve understanding of HD in China.
Abstract

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...